After evaluating more than 30 projects for France 2030 and Bpifrance, the conclusion is implacable: only 3 out of 10 make it through to operational deployment.<\/strong><\/p>\n\n But why?<\/strong> It’s never the technology. It’s always the organization. <\/p>\n\n A start-up develops a promising algorithm over 18 months.<\/strong><\/p>\n\n 3 months to launch: discovery that medical device classification requires a further 24 months’ clinical study. Budget exhausted. Project abandoned. <\/strong><\/p>\n\n A brilliant technical solution is designed without consulting end-users.<\/strong><\/p>\n\n The result? Virtually zero adoption.<\/strong> Caregivers find the interface unsuited to their daily workflow.<\/p>\n\n A telemedicine tool is built without cybersecurity analysis.<\/strong><\/p>\n\n First HDS audit: 47 critical non-conformities.<\/strong> Complete overhaul necessary.<\/p>\n\n What do they have in common?<\/strong> The absence of a structured methodology that simultaneously integrates technical, regulatory, human and business aspects.<\/p>\n\n My approach combines three rarely connected universes:<\/p>\n\n 17 years with the French Army Health Service:<\/strong> structuring projects in constrained environments where error is not an option. In an overseas operation<\/strong>, when your telemedicine system has to operate at 45\u00b0C with an unstable satellite connection, you develop an obsession with resilience.<\/p>\n\n Scale-up HealthTech:<\/strong> expansion director, I deployed e-health solutions in 12 European countries. I’ ve experienced the pitfalls:<\/strong> multi-country compliance, cultural adaptation, organizational complexity.<\/p>\n\n France 2030 expert:<\/strong> as an evaluator for Bpifrance, I have developed a precise reading grid of success\/failure factors. Unique observatory position<\/strong> on what really works.<\/p>\n\n Hybridization:<\/strong> military rigor (risk management) + Lean Startup (rapid field validation) + generative AI (prototyping acceleration). This alignment reconciles agility and compliance<\/strong>, speed and security.<\/p>\n\n The pitfall:<\/strong> Develop for 18 months, then discover the regulatory constraints.<\/p>\n\n The approach:<\/strong> Regulatory integration from D1, with adaptive roadmap.<\/p>\n\n Why?<\/strong> The healthcare sector is the most regulated in the world. MDR\/IVDR, RGPD<\/a><\/strong>HDS, NIS2 cybersecurity… Each regulation impacts technical architecture and timeline. <\/p>\n\n What we do differently:<\/strong><\/p>\n\n The trap:<\/strong> “Our product is great, it will sell itself.”<\/p>\n\n The approach:<\/strong> market validation before line of code, sales strategy adapted to healthcare sales cycles (18-36 months).<\/p>\n\n Why is this so?<\/strong> The healthcare market is not a classic B2B market. Multiple decision-makers<\/strong> (management, CIOs, doctors, IMGs) with conflicting objectives. Rigid budgets. Standardized purchasing processes. <\/p>\n\n Customer case:<\/strong> Startup bed management tool. Targeted CIOs (buyers). But real prescribers = healthcare executives<\/strong> (users). Pivot:<\/strong> 0 \u2192 12 CHU customers in 18 months. <\/p>\n\n The catch:<\/strong> “We’ll deal with cybersecurity later.”<\/p>\n\n The approach:<\/strong> Security by design, native RGPD compliance, HDS anticipation.<\/p>\n\n Key figure:<\/strong> +55% cyber attacks on French healthcare establishments by 2024.<\/p>\n\n A single data leak = lethal<\/strong> for a startup. CNIL sanctions up to 4% of worldwide sales. Loss of trust. Impossible HDS certification. <\/p>\n\n Our framework :<\/strong><\/p>\n\n Gain:<\/strong> No post-launch migration. Integrated security = savings of \u20ac150-300K. <\/p>\n\n The catch:<\/strong> “We’ll make the connectors if the customers ask for them.”<\/p>\n\n The approach:<\/strong> Interoperability right from the MVP stage, open standards (FHIR<\/a><\/strong>), prioritized connector strategy.<\/p>\n\n The reality:<\/strong> Healthcare establishments use 50-150 different software packages. Your solution needs to integrate<\/strong>, not work in silos.<\/p>\n\n Example of failure:<\/strong> brilliant AI tool for clinical decision support. But forced doctors to manually re-enter 15 fields<\/strong> already in the DPI. 4 minutes\/patient \u00d7 30 consultations = 2 hours lost\/day. Adoption < 5%. Project abandoned. <\/strong><\/p>\n\n The trap:<\/strong> “We’ve made a beautiful interface, users will adapt.”<\/p>\n\n The approach:<\/strong> Co-design with end-users, business UX adapted to field constraints.<\/p>\n\n Health UX specificities:<\/strong> frequent interruptions (every 4 min), high cognitive stress, heterogeneous digital skills, safety imperative (UX error = serious clinical consequence).<\/p>\n\n Methodology :<\/strong><\/p>\n\n Success indicator:<\/strong> SUS > 75\/100, adoption > 70% at 3 months post-deployment.<\/p>\n\n The catch:<\/strong> “We train our algorithm on open source data, that’s enough.”<\/p>\n\n The approach:<\/strong> responsible AI, clinical explicability, rigorous validation, ethical governance.<\/p>\n\n Why is this?<\/strong> Healthcare AI is not consumer AI. A diagnostic algorithm that gets it wrong = potentially fatal medical error<\/strong>, medico-legal liability, impact on trust in the healthcare system.<\/p>\n\n Real case:<\/strong> Readmission prediction algorithm developed on data from Paris University Hospital. Excellent test performance (AUC 0.89). Rural UHC deployment: poor performance<\/strong> (AUC 0.62). Population bias not detected. Delay 8 months. <\/p>\n\n Framework IA responsible :<\/strong><\/p>\n\n Startup:<\/strong> Remote monitoring solution for heart failure patients<\/p>\n\n Initial stage:<\/strong> Pre-seed, technical prototype, 0 customers<\/p>\n\n Objective:<\/strong> CE marking + 3 pilot university hospitals in 18 months<\/p>\n\n Month 1-2: Audit reveals<\/strong><\/p>\n\n Structuring results :<\/strong><\/p>\n\n At 18 months :<\/strong><\/p>\n\n Key success factor:<\/strong> User pivot identified Month 2. Without structuring, discovery Month 12+ = critical loss of time\/money.<\/strong><\/p>\n\n Error 1: False technological priority<\/strong><\/p>\n\n “We’re developing our revolutionary AI for 18 months, then we’ll look at the regulations.”<\/p>\n\n \u2192 Regulatory compliance IS the limiting factor.<\/p>\n\n Error 2: “We know better than the users” syndrome<\/strong><\/p>\n\n “Our team understands the problem, no need for interviews.”<\/p>\n\n \u2192 80% of founding hypotheses are invalidated by the field.<\/p>\n\n Error 3: Cosmetic safety<\/strong><\/p>\n\n “We’ll put in HTTPS and a password for the MVP.”<\/p>\n\n \u2192 A security flaw instantly destroys trust.<\/p>\n\n Error 4: The digital island<\/strong><\/p>\n\n “We’ll make the connectors if the customers ask for them.”<\/p>\n\n \u2192 A solution that doesn’t fit in will never be adopted.<\/p>\n\n Error 5: Black-box AI<\/strong><\/p>\n\n “Our algorithm works very well, no need to explain how.”<\/p>\n\n \u2192 Clinicians will never adopt an AI they don’t understand.<\/p>\n\n Where do you stand on each of the 6 pillars (scale 0-5)? <\/strong><\/p>\n\n
\n\nThe three pitfalls that kill projects<\/h2>\n\n
![\"\"](\"https:\/\/juliashift.eu\/wp-content\/uploads\/2025\/09\/20251109_1413_E-Health-Success-Pillars_simple_compose_01k9mbxxsafpkbt928frtjv9ay.png\")
\n\nWhere the JuliaShift method comes from<\/h2>\n\n
\n\nThe 6 pillars of structuring<\/h2>\n\n
Pillar 1: Regulatory expertise from Day 1<\/strong><\/h3>\n\n
\n
\n\nPillar 2: Strategic health go-to-market<\/strong><\/h3>\n\n
\n\nPillar 3: Data security and compliance<\/strong><\/h3>\n\n
\n
\n\nPillar 4: Open technical interoperability<\/strong><\/h3>\n\n
\n\nPillar 5: User-centered business design<\/strong><\/h3>\n\n
\n
\n\nPillar 6: AI and ethical data science<\/strong><\/h3>\n\n
\n
\n\nCase study: from 0 to 3 UHC customers in 18 months<\/h2>\n\n
\n
\n
\n
\n\n5 fatal mistakes to avoid<\/h2>\n\n
\n\n
\n\n
\n\n
\n\n
\n\nEvaluate your project: JuliaShift matrix<\/h2>\n\n